Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:32 PM
Ignite Modification Date:
2025-12-24 @ 10:32 PM
NCT ID:
NCT07269535
Eligibility Criteria:
1. Inclusion Criteria:
1.1 Patients clinically evaluated and radiologically examined (including MRI, particularly T2WI and DWI sequences) who are diagnosed with uterine leiomyoma or considered highly suspected of uterine sarcoma, in combination with preliminary pathological findings.
1.2 Patients scheduled for surgical treatment or those eligible for long-term standardized follow-up.
1.3 Patients who are able to understand the study procedures and voluntarily sign the written informed consent form.
2. Exclusion Criteria:
2.1 Patients with severe organic diseases or a previous confirmed diagnosis of other malignant uterine tumors.
2.2 Patients unable to complete baseline examinations, unable to comply with long-term follow-up, or unwilling to provide written informed consent.
Healthy Volunteers:
False
Sex:
FEMALE
Study:
NCT07269535
Study Brief:
Protocol Section:
NCT07269535